ConductScience.org, home

Library / Genes

KRT20: keratin 20

1 protein, 25 patents, 0 drugs, 0 trials, 13,166 NIH grants and 66,736 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKRT20HGNC
Namekeratin 20HGNC
NCBI Gene ID54474NCBI Gene
HGNC IDHGNC:20412HGNC
EnsemblENSG00000171431NCBI Gene
AliasesCD20, CK-20, CK20, K20, KRT21, MGC35423NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P35900Keratin, type I cytoskeletal 204240Ensembl, GeneID, HGNCUniProt

Patents 25

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1450664P35900Espacenet
WO 2025215055 A12025-10-16145P35900Espacenet
US 11896678 B22024-02-1318P35900Espacenet
JP 2023533815 A2023-08-043P35900Espacenet
KR 1020230068378 A2023-05-173P35900Espacenet
US 11446398 B22022-09-2042962P35900Espacenet
US 11446398 B22022-09-2042963P35900Espacenet
JP 2022524081 A2022-04-27145933P35900Espacenet
JP 2022524081 A2022-04-27145934P35900Espacenet
US 11262358 B22022-03-0113P35900Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 13166

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant4462,025NIH's project files
P30CA016672Cancer Center Support Grant4062,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award1082,025NIH's project files
P51OD011132Emory National Primate Research Center832,025NIH's project files
P30CA006973Regional Oncology Research Center822,025NIH's project files
ZIASC000550Lymphoma Disease Discovery and Definition792,025NIH's project files
P30CA016058Cancer Center Support Grant782,025NIH's project files
P30CA015704Cancer Center Support Grant722,025NIH's project files
ZIABC011070Hematopathology Diagnosis652,025NIH's project files
P51OD011092Support for National Primate Research Center602,025NIH's project files

Papers 66736

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827143PubTator, text miningPubMed
42826002PubTator, text miningPubMed
42824951PubTator, text miningPubMed
42824425PubTator, text miningPubMed
42822009PubTator, text miningPubMed
42821349PubTator, text miningPubMed
42820842PubTator, text miningPubMed
42818786PubTator, text miningPubMed
42818477PubTator, text miningPubMed
42816411PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license